Drug Resistance in Plasmodium Falciparum from Thailand

Martin D. Young
Search for other papers by Martin D. Young in
Current site
Google Scholar
PubMed
Close
,
Peter G. Contacos
Search for other papers by Peter G. Contacos in
Current site
Google Scholar
PubMed
Close
,
Joseph E. Stitcher
Search for other papers by Joseph E. Stitcher in
Current site
Google Scholar
PubMed
Close
, and
Jack W. Willar
Search for other papers by Jack W. Willar in
Current site
Google Scholar
PubMed
Close
Restricted access

Summary

A strain (JHK) of Plasmodium falciparum, apparently originating in Thailand, has been studied in seven patients for its response to various drugs.

The parasites showed a poor or no response to the usual therapeutic doses of the following drugs: chloroquine, amopyroquine, pyrimethamine, proguanil, and a new hydroxynaphthalene derivative. The parasites responded rapidly to mepacrine but relapsed. Weekly suppressive doses of chloroquine failed to prevent the mosquito transmission to and the occurrence of the infections in the recipients. Pyrimethamine failed to exert sporontocidal effect. Pyrimethamine combined with either chloroquine or amodiaquine demonstrated no advantage over these drugs singly.

The infections were cured by regimens of 8 g or more of quinine and appeared to be very sensitive to even small amounts of this drug.

Author Notes

Laboratory of Parasite Chemotherapy, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda 14, Maryland and Atlanta, Georgia.

Lieutenant Commander, Medical Corps, U. S. Navy. National Naval Medical Center, Bethesda 14, Maryland.

Commander, Medical Corps, U. S. Navy. Preventive Medicine Division, Bureau of Medicine and Surgery, Department of the Navy, Washington 25, D. C.

Save